Rebamipide as a Potential Alternative Gastroprotective Agent to Proton Pump Inhibitor in Elderly Chronic Nonsteroidal Anti-Inflammatory Drug Users without Risk Factors-Reference-Cited by-同舟云学术

Rebamipide as a Potential Alternative Gastroprotective Agent to Proton Pump Inhibitor in Elderly Chronic Nonsteroidal Anti-Inflammatory Drug Users without Risk Factors

Published:2022-03 Issue: Volume:Volume 15 Page:2835-2845
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Lee Mee Yeon,Lee Suhyun,Heo Kyu-Nam,Kim Woo-Youn,Jung Sun Hoi,Ah Young-Mi^ORCID,Lee Ju-Yeun^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference18 articles.

1. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage

2. NSAID and Aspirin Use by the Elderly in General Practice

3. ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

4. Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous co-prescription of rebamipide prevents upper gastrointestinal bleeding in NSAID use for orthopaedic conditions: A nested case-control study using the LIFE Study database;PLOS ONE;2024-06-11

2. Berberine mitigates diclofenac-induced intestinal mucosal mechanical barrier dysfunction through the restoration of autophagy by inhibiting exosome-mediated lncRNA H19;Inflammopharmacology;2024-05-17

3. Gastroprotective therapy in patients with atrial fibrillation receiving anticoagulant therapy: A review;Consilium Medicum;2023-07-30

4. Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study;Journal of Molecular Graphics and Modelling;2023-07

5. Inappropriate Use of Proton Pump Inhibitors Increases Cardiovascular Events in Patients with Coronary Heart Disease;International Journal of General Medicine;2022-12